A Study of Rituximab and Ifosfamide, Carboplatin, and Etoposide Chemotherapy in Children with Recurrent/Refractory B-cell (CD20+) Non-Hodgkin Lymphoma and Mature B-Cell Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group

BACKGROUND: To estimate the response rate and therapy related toxicities of the anti-CD20 monoclonal antibody rituximab when combined with chemotherapy including ifosfamide, carboplatin, and etoposide (ICE) in patients with relapsed and refractory B-cell non-Hodgkin lymphoma and mature B-cell acute...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Griffin, Timothy C., Weitzman, Sheila, Weinstein, Howard, Chang, Myron, Cairo, Mitchell, Hutchison, Robert, Shiramizu, Bruce, Wiley, Joseph, Woods, Deborah, Barnich, Margaret, Gross, Thomas G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2009
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2728935/
https://ncbi.nlm.nih.gov/pubmed/18816698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.21753
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi